lenalidomide
Showing 1026 - 1050 of 1,173
Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia Trial in Buffalo
Withdrawn
- Chronic Lymphocytic Leukemia
- +2 more
- Diagnostic Laboratory Biomarker Analysis
- Lenalidomide
-
Buffalo, New YorkRoswell Park Cancer Institute
Jun 3, 2015
Myeloma Trial in Houston (Lenalidomide, Bortezomib, Siltuximab)
Completed
- Myeloma
- Lenalidomide
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 2, 2015
Multiple Myeloma Trial in Little Rock (Revlimid)
Completed
- Multiple Myeloma
-
Little Rock, ArkansasUniversity of Arkansas for Medical Science-MIRT
Sep 29, 2015
Multiple Myeloma Trial in Hamburg, Heidelberg (Revlimid (Lenalidomide))
Completed
- Multiple Myeloma
- Revlimid (Lenalidomide)
-
Hamburg, Germany
- +1 more
May 12, 2015
Acute Myeloid Leukemia Trial in Toronto (Revlimid)
Completed
- Acute Myeloid Leukemia
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Jun 17, 2015
Anemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia Trial in Columbus (Alvocidib Hydrochloride, Lenalidomide,
Completed
- Anemia
- +5 more
- Alvocidib Hydrochloride
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 1, 2015
Refractory Plasma Cell Myeloma Trial in Aurora (Bortezomib, Lenalidomide, Dexamethasone)
Terminated
- Refractory Plasma Cell Myeloma
- Bortezomib
- +2 more
-
Aurora, ColoradoUniversity of Colorado
Feb 23, 2015
Multiple Myeloma, Refractory Multiple Myeloma, Stage I Multiple Myeloma Trial in Scottsdale, Rochester (plerixafor, filgrastim)
Completed
- Multiple Myeloma
- +4 more
-
Scottsdale, Arizona
- +1 more
Apr 24, 2015
Leukemia, Lymphoma Trial (rituximab, lenalidomide)
Withdrawn
- Leukemia
- Lymphoma
- rituximab
- lenalidomide
- (no location specified)
Mar 4, 2015
Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma Trial in Washington (bendamustine and lenalidomide, BL-NHL, BLR-CLL)
Completed
- Chronic Lymphocytic Leukemia
- Non-Hodgkin's Lymphoma
- bendamustine and lenalidomide
- +3 more
-
Washington, District of ColumbiaGeorgetown University Hospital/Lombardi Cancer Center
Mar 12, 2015
Multiple Myeloma, Plasma Cell Tumor Trial in Royal Oak, Salt Lake City (dexamethasone, lenalidomide, )
Completed
- Multiple Myeloma
- Plasma Cell Neoplasm
- dexamethasone
- +2 more
-
Royal Oak, Michigan
- +1 more
Mar 5, 2015
Myelodysplastic Syndrome MDS Trial in Germany (Valproic aicd, Lenalidomide)
Terminated
- Myelodysplastic Syndrome MDS
- Valproic aicd
- Lenalidomide
-
Freiburg, Baden Würtemberg, Germany
- +5 more
Mar 17, 2015
Chronic Myelomonocytic Leukemia Trial in Austria (Revlimid)
Unknown status
- Chronic Myelomonocytic Leukemia
-
Linz, Oberösterreich, Austria
- +9 more
Mar 6, 2015
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in France (Lenalidomide)
Unknown status
- Myelodysplastic Syndrome
- +2 more
- Lenalidomide
-
Angers, France
- +24 more
Apr 23, 2015
Brain and CNS Tumors Trial run by the NCI (lenalidomide)
Completed
- Brain and Central Nervous System Tumors
- lenalidomide
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Apr 29, 2015
Squamous Cell Carcinoma Trial in Chicago (Cetuximab and Lenalidomide)
Completed
- Squamous Cell Carcinoma
- Cetuximab and Lenalidomide
-
Chicago, IllinoisThe University of Chicago
Nov 17, 2014
Myelodysplasic Syndromes and Risk Factors for Infection
Unknown status
- Myelodysplastic Syndrome (MDS)
- +3 more
- No intervention
-
Creteil, FranceHenri Mondor Hospital
Dec 20, 2016
Multiple Myeloma Trial in Worldwide (Cyclophosphamide, Bortezomib, Dexamethasone)
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +12 more
- Lenalidomide
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 22, 2014
Chronic Lymphocytic Leukemia Trial in New Haven (Maintenance lenalidomide)
Terminated
- Chronic Lymphocytic Leukemia
- Maintenance lenalidomide
-
New Haven, ConnecticutYale Cancer Center
Oct 22, 2014